SIGA Technologies (NASDAQ:SIGA) Shares Gap Down to $8.76

SIGA Technologies, Inc. (NASDAQ:SIGA)’s share price gapped down before the market opened on Monday . The stock had previously closed at $8.76, but opened at $8.11. SIGA Technologies shares last traded at $8.18, with a volume of 253,139 shares.

SIGA Technologies Stock Down 0.4 %

The business’s 50 day moving average is $5.62 and its 200 day moving average is $5.40. The company has a market cap of $591.47 million, a P/E ratio of 8.76 and a beta of 0.85.

SIGA Technologies Increases Dividend

The company also recently announced a dividend, which will be paid on Thursday, April 11th. Shareholders of record on Tuesday, March 26th will be paid a $0.60 dividend. This is an increase from SIGA Technologies’s previous dividend of $0.45. The ex-dividend date of this dividend is Monday, March 25th.

Institutional Trading of SIGA Technologies

A number of institutional investors have recently made changes to their positions in the business. Point72 Middle East FZE purchased a new stake in SIGA Technologies in the fourth quarter valued at about $27,000. Tower Research Capital LLC TRC increased its stake in SIGA Technologies by 200.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,955 shares of the company’s stock valued at $45,000 after purchasing an additional 5,309 shares in the last quarter. China Universal Asset Management Co. Ltd. raised its holdings in shares of SIGA Technologies by 351.7% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 8,225 shares of the company’s stock worth $46,000 after buying an additional 6,404 shares during the last quarter. UBS Group AG lifted its stake in shares of SIGA Technologies by 30.3% during the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock worth $53,000 after buying an additional 1,070 shares during the period. Finally, Evergreen Capital Management LLC purchased a new stake in SIGA Technologies during the 3rd quarter valued at about $57,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.